Cardiff Oncology Inc Call on Updated Phase 2 CRDF-004 Transcript
Ladies and gentlemen, thank you for standing by. Welcome to the Cardif Oncology ASCO data presentation conference call. (Operator Instructions) . Please be advised that today's conference is being recorded.
I would like now to turn the conference over to [Han Ertman of Astra Partners]. Please go ahead.
Thank you, operator. During this conference call, the Cardiff management team will make forward-looking statements, including, without limitation, statements related to guidance, results and the timing of data readouts for inventive clinical trials. These forward-looking statements are based on the company's current expectations and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties.
Factors that could cause results to be different from these statements include factors the company describes in the section titled Risk Factors in its annual report on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
